Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Pesquin becomes CEO at AskBio

Plus: Emmenegger to be CFO at Owkin and an update from Agios

March 11, 2023 1:28 AM UTC

Gustavo Pesquin will become CEO at Asklepios BioPharmaceutical Inc. (AskBio) on March 11, succeeding co-founder and CEO Sheila Mikhail, who will become a part-time adviser. Pesquin, a veteran of Sanofi (Euronext:SAN; NASDAQ:SNY), was chief commercial officer at Amneal Pharmaceuticals Inc. (NYSE:AMRX). Asklepios is a subsidiary of Bayer AG (Xetra:BAYN).

AI-based medical research company Owkin Inc. hired Andreas Emmenegger to be its first CFO. Emmenegger was CFO of Molecular Partners AG (SIX:MOLN; NASDAQ:MOLN) from 2007 to 2022...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article